Other OTC - Delayed Quote USD

Bionik Laboratories Corp. (BNKL)

0.0000 0.0000 (0.00%)
At close: November 29 at 9:33 AM EST
Key Events
Loading Chart for BNKL
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 1.4500
  • Volume 1,000
  • Avg. Volume 0
  • Market Cap (intraday) 12
  • Beta (5Y Monthly) -1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7200
  • Earnings Date Feb 6, 2024 - Feb 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

www.bioniklabs.com

12

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BNKL

Performance Overview: BNKL

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BNKL
100.00%
S&P 500
6.92%

1-Year Return

BNKL
100.00%
S&P 500
25.26%

3-Year Return

BNKL
100.00%
S&P 500
22.00%

5-Year Return

BNKL
100.00%
S&P 500
74.29%

Compare To: BNKL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BNKL

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    1.25M

  • Enterprise Value

    3.23M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.38

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.79

  • Enterprise Value/EBITDA

    -0.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -273.99%

  • Return on Assets (ttm)

    -74.23%

  • Return on Equity (ttm)

    -768.84%

  • Revenue (ttm)

    1.81M

  • Net Income Avi to Common (ttm)

    -4.95M

  • Diluted EPS (ttm)

    -0.7200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    427.38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.58M

Company Insights: BNKL

Fair Value

0.0000 Current
 

Dividend Score

0 Low
BNKL
Sector Avg.
100 High
 

Hiring Score

0 Low
BNKL
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
BNKL
Sector Avg.
100 High